Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|4|3|191-196

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.3, 2003-04, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia-directed cancer therapy

By Frazier Monica C   Simons Jonathan W   Zhong Hua   Mabjeesh Nicola J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia Inducible Factor as a Cancer Drug Target

By  

Current Cancer Drug Targets, Vol. 3, Iss. 6, 2003-12 ,pp. : 391-405

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia in DU-145 Prostate Cancer Xenografts after Estramustine Phosphate and Radiotherapy

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 19-24

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia in Du-145 Prostate Cancer Xenografts After Estramustine Phosphate and Radiotherapy

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 4, 2010-10 ,pp. : 297-303

Bentham Science Publishers

Access to resources Recommend Favorite